This is because overseas manufacturers and suppliers operate outside Australian jurisdiction, and therefore cannot be compelled to comply with the Therapeutic Goods Act 1989 (Cth) or any other Australian therapeutic goods legislation. New regulations in New Zealand In May 2026, the New Zealand Medicines and Medical Devices Safety Authority (Medsafe) issued a formal consumer advisory warning New Zealanders against purchasing or using unapproved synthetic peptides and Selective Androgen Receptor Modulators (SARMs) promoted online
Unlike many other peptides, DSIP has no single, clearly defined receptor
10.3389/fmicb.2023.1190894 177 HeQ.WangW.XuD.XiongY.TaoC.YouC.et al
376 , 377 , 378 , 379 , 380 , 381 , 382 Data from the CHAP study indicates 19% of Black and 14% of Hispanic adults age 65 and older have Alzheimer's dementia compared with 10% of White older adults
These studies are exploratory and intended to clarify mechanisms, with no human or veterinary purpose